These 10 Firms Led This Week’s Rally

1. Inari Medical Inc. (NASDAQ:NARI)

Despite dipping by a marginal 0.01 percent on Friday from Wednesday’s trading, shares of Inari Medical (NARI) soared by nearly 52 percent week-on-week to end at $79.29 apiece.

Investor sentiment was buoyed by an announcement of a definitive agreement from Stryker involving the latter’s acquisition of Inari Medical for approximately $4.9 billion.

Inari Medical (NARI) is expected to enhance Stryker’s portfolio by expanding its treatment options for venous thromboembolism (VTE), a condition characterized by blood-vein clotting, and other venous diseases through clot removal without the use of thrombolytic drugs.

Each year, VTE impacts nearly one million lives in the United States, mostly those undergoing hospitalization, cancer treatment, and during or after pregnancy.

While we acknowledge the potential of NARI as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NARI but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

Disclosure: None. This article is originally published at Insider Monkey.